ICARES Medicus, Inc.
Research ICARES Medicus, Inc. (6612.TWO) on Bullrun: market cap TWD 3.27B, P/E 38.8, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6612.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyTWD
- Market capTWD 3.27B
- P/E38.8
- Dividend yield0.4%
- Financial periodQ2 2026
- RevenueTWD 347.66M
- Net incomeTWD 34.32M
- Free cash flowTWD 38.41M
- Gross margin52.1%
Valuation Snapshot
latest market cap is TWD 3.27B; P/E is 38.8; dividend yield is 0.4%.
Peer valuation comparison
Latest P/E is 38.83x versus a Healthcare sector median of 21.8x (78.1% above).
Latest dividend yield is 0.44% versus a Healthcare sector median of 2.4% (81.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 3.27B | 38.8 | 0.4% | 0.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.3 TWD, yield 0.4%.
About ICARES Medicus, Inc.
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services.
ETFs that hold ICARES Medicus, Inc.
US-listed ETFs
ICARES Medicus, Inc. is held by 3 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.01% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ICARES Medicus, Inc.'s market cap?
ICARES Medicus, Inc.'s market capitalization is TWD 3.27B.
What is ICARES Medicus, Inc.'s P/E ratio?
ICARES Medicus, Inc.'s price-to-earnings (P/E) ratio is 38.8.
Does ICARES Medicus, Inc. pay a dividend?
ICARES Medicus, Inc. has a dividend yield of 0.4%.
What does ICARES Medicus, Inc. do?
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services.